Jia Shen1, Joseph C Poole1, Matthew L Topel1, Aurelian Bidulescu1, Alanna A Morris1, Riyaz S Patel1, Jose G Binongo1, Sandra B Dunbar1, Lawrence Phillips1, Viola Vaccarino1, Gary H Gibbons1, Arshed A Quyyumi1. 1. Emory Clinical Cardiovascular Research Institute (J.S., J.C.P., A.A.M., V.V., A.A.Q.), Emory University School of Medicine (M.L.T., L.P.), Department of Biostatistics and Bioinformatics (J.G.B.), Emory Rollins School of Public Health, and Emory University, School of Nursing (S.B.D.), Atlanta, Georgia 30322; Cardiovascular Research Institute (A.B.), Morehouse School of Medicine, Atlanta, Georgia 30310; Institute of Cardiovascular Science (R.S.P.), University College London, London WC1E 6BT, United Kingdom; and National Institutes of Health/National Heart, Lung, and Blood Institute (G.H.G.), Bethesda, Maryland 20824.
Abstract
CONTEXT: The diagnosis of metabolic syndrome (MetS) identifies individuals at risk for developing diabetes and cardiovascular disease. African Americans (AAs) have high rates of cardiovascular disease and subclinical vascular disease including arterial stiffness and microvascular dysfunction but have relatively low rates of MetS. OBJECTIVE: The objective of the study was to evaluate the relationship between MetS and vascular function in a biracial cohort with the hypothesis that the diagnosis of MetS underestimates subclinical vascular disease in AAs. DESIGN: We measured components of MetS in a community-based cohort of 951 AAs and white subjects (aged 48.8 ± 11 y, 47% AA, 55% female). MAIN OUTCOME MEASURES: Using digital pulse amplitude tonometry, we estimated the reactive hyperemia index (RHI), a measure of microvascular endothelial function. Using applanation tonometry (Sphygmocor), central augmentation index (CAIx) and pulse wave velocity (PWV) were measured as indices of wave reflections and arterial stiffness, respectively. RESULTS: MetS was present in 24.0% of subjects and was associated with increased PWV (P < .001) and CAIx (P < .001) and a trend to lower RHI (P = .068) in both races. However, in subjects without MetS, AAs had lower RHI (P < .001) and higher PWV (P = .003) and CAIx (P = .002) compared with white subjects. Addition of an extra MetS criterion point for AAs with hypertension eliminated the racial differences in PWV and CAIx but not RHI. CONCLUSION: Although MetS is associated with microvascular dysfunction and increased arterial stiffness in both racial groups, AAs without MetS have greater vascular dysfunction compared with whites. Additional weighting for hypertension in AAs attenuated the racial differences in subclinical disease associated with MetS.
CONTEXT: The diagnosis of metabolic syndrome (MetS) identifies individuals at risk for developing diabetes and cardiovascular disease. African Americans (AAs) have high rates of cardiovascular disease and subclinical vascular disease including arterial stiffness and microvascular dysfunction but have relatively low rates of MetS. OBJECTIVE: The objective of the study was to evaluate the relationship between MetS and vascular function in a biracial cohort with the hypothesis that the diagnosis of MetS underestimates subclinical vascular disease in AAs. DESIGN: We measured components of MetS in a community-based cohort of 951 AAs and white subjects (aged 48.8 ± 11 y, 47% AA, 55% female). MAIN OUTCOME MEASURES: Using digital pulse amplitude tonometry, we estimated the reactive hyperemia index (RHI), a measure of microvascular endothelial function. Using applanation tonometry (Sphygmocor), central augmentation index (CAIx) and pulse wave velocity (PWV) were measured as indices of wave reflections and arterial stiffness, respectively. RESULTS: MetS was present in 24.0% of subjects and was associated with increased PWV (P < .001) and CAIx (P < .001) and a trend to lower RHI (P = .068) in both races. However, in subjects without MetS, AAs had lower RHI (P < .001) and higher PWV (P = .003) and CAIx (P = .002) compared with white subjects. Addition of an extra MetS criterion point for AAs with hypertension eliminated the racial differences in PWV and CAIx but not RHI. CONCLUSION: Although MetS is associated with microvascular dysfunction and increased arterial stiffness in both racial groups, AAs without MetS have greater vascular dysfunction compared with whites. Additional weighting for hypertension in AAs attenuated the racial differences in subclinical disease associated with MetS.
Authors: A J Karter; E J Mayer-Davis; J V Selby; R B D'Agostino; S M Haffner; P Sholinsky; R Bergman; M F Saad; R F Hamman Journal: Diabetes Date: 1996-11 Impact factor: 9.461
Authors: Piero O Bonetti; Gregory W Barsness; Paul C Keelan; Theresa I Schnell; Geralyn M Pumper; Jeffrey T Kuvin; Robert P Schnall; David R Holmes; Stuart T Higano; Amir Lerman Journal: J Am Coll Cardiol Date: 2003-05-21 Impact factor: 24.094
Authors: Isabel Ferreira; Colin A Boreham; Jos W R Twisk; Alison M Gallagher; Ian S Young; Liam J Murray; Coen D A Stehouwer Journal: J Hypertens Date: 2007-05 Impact factor: 4.844
Authors: Brett J Wong; Casey G Turner; James T Miller; Demetria C Walker; Yesser Sebeh; Matthew J Hayat; Jeffrey S Otis; Arshed A Quyyumi Journal: Am J Physiol Heart Circ Physiol Date: 2020-06-19 Impact factor: 4.733
Authors: Matthew L Topel; Jia Shen; Alanna A Morris; Ibhar Al Mheid; Salman Sher; Sandra B Dunbar; Viola Vaccarino; Laurence S Sperling; Gary H Gibbons; Greg S Martin; Arshed A Quyyumi Journal: Am J Cardiol Date: 2017-12-12 Impact factor: 2.778
Authors: Timothy M Hughes; Kaycee M Sink; Jeff D Williamson; Christina E Hugenschmidt; Benjamin C Wagner; Christopher T Whitlow; Jianzhao Xu; S Carrie Smith; Lenore J Launer; Joshua I Barzilay; Faramarz Ismail-Beigi; R Nick Bryan; Fang-Chi Hsu; Donald W Bowden; Joseph A Maldjian; Jasmin Divers; Barry I Freedman Journal: J Diabetes Complications Date: 2018-05-29 Impact factor: 2.852
Authors: Timothy M Hughes; Lynne E Wagenknecht; Suzanne Craft; Akiva Mintz; Gerardo Heiss; Priya Palta; Dean Wong; Yun Zhou; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Neurology Date: 2018-03-16 Impact factor: 11.800